N6-methyladenosine (m<sup>6</sup>A) modification of TXNIP in 3'UTR instigates abdominal aorta aneurysm in mice. [PDF]
Hantelys F, Yin W, Zou MH.
europepmc +1 more source
PXDN regulated by WTAP/YTHDF1-mediated m<sup>6</sup>A modification activates PI3K/AKT signaling pathway through extracellular matrix remodeling to promote progression in nasopharyngeal carcinoma. [PDF]
Li Y +10 more
europepmc +1 more source
The epitranscriptome in gastric cancer: the role of m6A mRNA modifications [PDF]
Luís Filipe Costa Póvoas
core
RNA modifications in cancer stem cells: molecular mechanisms and targeted therapeutic strategies. [PDF]
Zhang J, Yuan Y, Li C, Jiang X, Song W.
europepmc +1 more source
RBM15 mediates m6A methylation modification of FOSB mRNA to promote dysfunction of trophoblast cells-a potential link to preeclampsia. [PDF]
Li Y, Li F, Gao Q.
europepmc +1 more source
Machine Learning and Experimental Validation of m6A RNA Methylation Related Signatures for Risk Prediction, Diagnostic Biomarkers, and Immune Subtypes in Chronic Kidney Disease. [PDF]
Chen J, Wang Z, Liao Y, Ding W.
europepmc +1 more source
The Roles and Implications of m6A Methylation in Radiotherapy for Gastrointestinal Tumors. [PDF]
Bi J, Hu W, Bian H, Cheng W.
europepmc +1 more source
N6-methyladenosine (m6A) of LINC01315 promotes hepatocellular carcinoma progression by activating β-Catentin/WNT pathway. [PDF]
Xing MX +5 more
europepmc +1 more source

